BMA
ME

Brooks Moore & Associates’s 23andMe Holding Co ME Stock Holding History

Brooks Moore & Associates’s Portfolio ME Stock Details ME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-768
Closed -$59K – 99
2022
Q1 		$59K Buy
+768
New +$70.1K 0.04% 97

Other funds holding ME

NCPI
NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
SV
Sapphire Ventures Austin, Texas $99.4M AUM 23.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brooks Moore & Associates's ME Position: Q2 2022 in Review

Brooks Moore & Associates sold out of 23andMe Holding Co (ME) in Q2 2022, closing a stake of 768 shares — an estimated $59K sold.

Brooks Moore & Associates first reported a position in ME in Q1 2022 and held it in 1 quarter. The position peaked at $59K in Q1 2022. 179 funds tracked by Wall St. Rank hold ME as of Q2 2022.

  • Brooks Moore & Associates reported no remaining 23andMe Holding Co position as of Q2 2022 after selling out during the quarter.
  • Brooks Moore & Associates sold 768 23andMe Holding Co shares in Q2 2022, an estimated $59K.
  • Brooks Moore & Associates first reported a position in 23andMe Holding Co in Q1 2022 and held it in 1 quarter.
  • Brooks Moore & Associates's 23andMe Holding Co position peaked at $59K in Q1 2022.
  • 179 funds tracked by Wall St. Rank held 23andMe Holding Co as of Q2 2022.

Based on Brooks Moore & Associates's 13F filing for Q2 2022, filed 4 Aug 2022.